Drug Profile
MEDI 4212
Alternative Names: MEDI-4212Latest Information Update: 09 Aug 2021
Price :
$50
*
At a glance
- Originator MedImmune
- Class Antiallergics; Antibodies
- Mechanism of Action IgE receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic asthma; Allergic rhinitis; Atopic dermatitis
Most Recent Events
- 30 Jun 2013 Discontinued - Phase-I for Allergic asthma in USA (IV)
- 30 Jun 2013 Discontinued - Phase-I for Allergic asthma in USA (SC)
- 30 Jun 2013 Discontinued - Phase-I for Allergic rhinitis in USA (IV)